Walker Matthew Allen's Form 4 filing
GreenLight Biosciences Holdings, PBC (GRNA) · filed Feb 4, 2022
- Accession no.
- 0001062993-22-002745
- Filed
- Feb 4, 2022, 8:22 PM ET
- Trade date
- Feb 2, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $15.0M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Walker Matthew AllenCIK 0001908721 | Director, 10% Owner |
| Builders Vision, LLCCIK 0001785504 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 2, 2022 | Common Stock | AGrant or awardAcquired | +14,343,021 | – | – | 14,343,021 | Indirect | |
| Feb 2, 2022 | Common Stock | PPurchaseAcquired | +1,500,000 | $10.00 | +$15,000,000 | 15,843,021 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.